PHILADELPHIA--(BUSINESS WIRE)--iCeutica, Inc. today announced a reformulation agreement with a leading ‘Big Pharma’ company. The agreement provides for iCeutica to reformulate a number of new chemical entities for the partner utilizing iCeutica’s SoluMatrix™ technology. Upon successful reformulation, the partner intends to guide progression of these reformulated products through the development and regulatory process and ultimate launch.
